2010 Annual Scientific Meeting and Exposition 2010 Annual ...

MAY 21 3PostersMonday AfternoonMorning9:00 AM – 5:15 PM • Rhinelander GalleryCellular Mechanisms (Cell Biology;Cell Membrane Transport/Ion Channels;Coagulation/Thrombosis; GrowthFactors)PO-217: 1PO-218: 1PO-219: 2Transforming Growth Factor-β (TGF-β)-mediatedthe Down-Regulation of Peroxisome Proliferator-Activated Receptorγ (PPARγ) in the PressureOverloaded HeartKaizheng Gong, Peng Li, Jason Lucas, Dongqi Xing,Baran Aksut, Fadi Hage, Qinglin Yang, Susan E. Nozell,Suzanne Oparil, Yiu-Fai Chen. Vascular Biology andHypertension Program, University of Alabama atBirmingham, US.Serum Phosphate in White Coat HypertensivePatients: Focus on Dipping Status and MetabolicSynromeV. Tzamou, 1 G. Vyssoulis, 1 E. Karpanou, 2 Stella-Maria Kyvelou, 1 T. Gialernios, 1 C. Stefanadis. 1 1 1stCardiology Clinic Athens University HippokrationHospital, GR and 2 Cardiology Clinic OnassisCardiosurgery Center, GR.Regulation of Manganese Superoxide DismutaseExpression in Cardiac Fibroblasts by Angiotensin IIPaul J. Lijnen, Robert H. Fagard. University of Leuven(KULeuven), Leuven, BE.Clinical TrialsPO-220: 1PO-221: 3Optimal Blood Pressure Control and All CauseMortality in a Clinical Practice SettingVasilios Papademetriou, 1 Richard Amdur, 1 MichaelDoumas, 2 Costas Tsioufis, 1 Peter Kokkinos, 1 CharlesFaselis, 2 Ross D. Fletcher. 1 1 VAMC and GeorgetownUniversity, Washington, DC, US; 2 VAMC and GeorgeWasgington University, US; 3 VAMC and GeorgetownUniversity, US; 4 VAMC and Georgetown University,US and 5 VAMC and Georgetown University, US.Effects of the Novel Angiotensin Receptor BlockerAzilsartan Medoxomil in Patients with PrimaryHypertensionGeorge Bakris†, 1 Domenic Sica, 2 Michael Weber, 3William B. White, 4 Alfonso Perez, 5 Charlie Cao, 5Stuart Kupfer. 5 1 University of Chicago, PritzkerSchool of Medicine, Chicago, IL, US; 2 VirginiaCommonwealth University Health System, Richmond,VA, US; 3 SUNY Downstate College of Medicine,New York, NY, US; 4 Univ. of Connecticut School ofMedicine, Farmington, CT, US and 5 Takeda GlobalResearch & Development, Deerfield, IL, US.1 Pathobiology Track 2 Translational Track 3 Therapy Track142